ROIV Roivant Sciences Ltd.
$38.88
Roivant Sciences Ltd. (ROIV) Earnings News
Earnings press releases, previews and reviews for Roivant Sciences Ltd. (ROIV), newest first. Our most recent is preview: Roivant's First Post-Launch Report Puts Brepacitinib and a Crowded Catalyst Calendar to the Test.
Monday
November 2, 2026
4:06 PM ET
Roivant's First Post-Launch Report Puts Brepacitinib and a Crowded Catalyst Calendar to the Test
Earnings Whispers · Preview
Wednesday
October 21, 2026
7:00 AM ET
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
Thursday
August 6, 2026
7:00 AM ET
Roivant Reports Financial Results for the First Quarter Ended June 30, 2026, and Provides Business Update
Thursday
July 23, 2026
4:05 PM ET
Roivant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
Wednesday
May 20, 2026
7:00 AM ET
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provides Business Update
Monday
May 11, 2026
4:05 PM ET
Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026 and Provide Business Update on Wednesday, May 20, 2026